BlackRock Group’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$5.75M Buy
582,094
+456,898
+365% +$5M ﹤0.01% 1113
2016
Q3
$1.51M Sell
125,196
-2,920
-2% -$29.8K ﹤0.01% 1807
2016
Q2
$1.11M Sell
128,116
-829
-0.6% -$8.18K ﹤0.01% 1921
2016
Q1
$1.22M Buy
128,945
+12,956
+11% +$122K ﹤0.01% 1833
2015
Q4
$2.01M Buy
115,989
+24,743
+27% +$394K ﹤0.01% 1480
2015
Q3
$1.23M Buy
91,246
+6,276
+7% +$126K ﹤0.01% 1767
2015
Q2
$1.92M Buy
84,970
+6,902
+9% +$121K ﹤0.01% 1580
2015
Q1
$1.11M Buy
78,068
+14,689
+23% +$212K ﹤0.01% 1813
2014
Q4
$612K Buy
63,379
+14,279
+29% +$127K ﹤0.01% 2155
2014
Q3
$447K Sell
49,100
-552
-1% -$5.26K ﹤0.01% 2215
2014
Q2
$490K Sell
49,652
-49,561
-50% -$420K ﹤0.01% 2204
2014
Q1
$1.26M Buy
99,213
+13,386
+16% +$199K ﹤0.01% 1871
2013
Q4
$1.29M Buy
85,827
+8,165
+11% +$105K ﹤0.01% 1825
2013
Q3
$858K Sell
77,662
-19,314
-20% -$161K ﹤0.01% 1995
2013
Q2
$772K Buy
+96,976
New +$618K ﹤0.01% 1912

Other funds holding HALO

BlackRock Group's HALO Position: Q4 2016 in Review

BlackRock Group increased its Halozyme (HALO) stake by 365% in Q4 2016, buying an estimated $5M and bringing the position to 582,094 shares worth $5.75M. The position accounts for ﹤0.01% of the portfolio, ranked #1113.

BlackRock Group first reported a position in HALO in Q2 2013 and has held it in 15 quarters since. 168 funds tracked by Wall St. Rank hold HALO as of Q4 2016.

  • BlackRock Group held 582,094 shares of Halozyme worth $5.75M as of Q4 2016.
  • BlackRock Group bought 456,898 Halozyme shares in Q4 2016, an estimated $5M.
  • Halozyme made up ﹤0.01% of BlackRock Group's portfolio in Q4 2016, its #1113 holding.
  • BlackRock Group first reported a position in Halozyme in Q2 2013 and has held it in 15 quarters since.
  • 168 funds tracked by Wall St. Rank held Halozyme as of Q4 2016.

Based on BlackRock Group's 13F filing for Q4 2016, filed 10 Feb 2017.